|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,511 GBX | +0.03% |
|
-1.21% | +4.19% |
| 07-05 | GSK: FIRST SINGLE-DOSE MEDICINE TO PREVENT RELAPSE OF P. VIVAX M… | RE |
| 07-05 | GSK launches antimalarial drug in Thailand and Brazil | CF |
Jan 6 (Reuters) - GlaxoSmithKline PLC:
* GSK ANNOUNCES ADDITIONAL PURCHASE AGREEMENTS WITH THE GOVERNMENT OF CANADA FOR COVID-19 MONOCLONAL ANTIBODY THERAPY, SOTROVIMAB
* GSK - HAS SIGNED AGREEMENTS WITH GOVERNMENT OF CANADA TO SUPPLY 20,000 DOSES OF SOTROVIMAB FOR INJECTION Source text for Eikon: Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +4.19% | 78.92B | |
| +56.89% | 823B | |
| +39.52% | 627B | |
| -6.55% | 353B | |
| +15.99% | 320B | |
| +7.92% | 295B | |
| +13.74% | 239B | |
| +13.83% | 220B | |
| -0.49% | 219B | |
| +7.94% | 167B |
GSK PLC 
